Valuation: Southern Acids (M)

Market Cap 415M 102M 89.05M 82.11M 75.88M 144M 9.71B 147M 984M 385M 4.78B 382M 374M 16.53B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.79M 10.31M 9.51M 8.78M 16.67M 1.12B 16.99M 114M 44.62M 553M 44.26M 43.3M 1.91B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
1 day+0.65%
1 week+2.31%
Current month-1.27%
3 months-0.32%
6 months-2.82%
Current year-2.52%
1 week 3.05
Extreme 3.05
3.12
1 month 3.03
Extreme 3.03
3.14
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 2015-07-14
Director of Finance/CFO 58 2013-09-30
Chief Tech/Sci/R&D Officer 38 2014-07-15
Director TitleAgeSince
Director/Board Member 66 2005-08-09
Director/Board Member 59 2012-03-19
Chairman 79 2015-07-14
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+2.31%-5.49%-10.14% 103M
-2.85%+8.79%+18.93%+345.20% 5.75B
+0.55%+2.52%+24.49%+100.00% 1.7B
-3.00%+5.18%+56.52%+20.92% 716M
+0.82%-10.12%+15.52%+40.65% 654M
-0.75%+2.01%+37.71%+99.10% 551M
-2.37%-1.47%-18.45%-29.05% 516M
-1.56%-7.47%+53.37%+0.64% 414M
+0.31%+4.75%+7.46%+5.16% 368M
-0.97%-1.69%+26.28%+60.37% 305M
Average -0.92%-2.17%+21.63%+63.28% 1.11B
Weighted average by Cap. -1.76%+0.97%+22.08%+203.67%

Financials

2024 2025
Net sales 920M 226M 197M 182M 168M 319M 21.54B 326M 2.18B 855M 10.59B 848M 830M 36.67B 1.11B 271M 237M 219M 202M 384M 25.89B 391M 2.62B 1.03B 12.73B 1.02B 997M 44.07B
Net income 13.63M 3.35M 2.93M 2.7M 2.49M 4.73M 319M 4.82M 32.34M 12.66M 157M 12.56M 12.29M 543M 36.7M 9.01M 7.88M 7.26M 6.71M 12.74M 859M 12.98M 87.05M 34.09M 423M 33.82M 33.09M 1.46B
Net Debt -372M -91.36M -79.88M -73.66M -68.07M -129M -8.71B -132M -883M -346M -4.28B -343M -336M -14.83B -367M -90.05M -78.74M -72.61M -67.1M -127M -8.59B -130M -870M -341M -4.22B -338M -331M -14.62B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
26-07-09 MYR 3.100 +0.65% 10,000
26-07-07 MYR 3.080 -0.65% 55,000
26-07-06 MYR 3.100 +2.31% 21,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock